1. Home
  2. PLBC vs SCLX Comparison

PLBC vs SCLX Comparison

Compare PLBC & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plumas Bancorp

PLBC

Plumas Bancorp

HOLD

Current Price

$46.63

Market Cap

316.6M

Sector

Finance

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$14.53

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLBC
SCLX
Founded
1980
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
316.6M
139.3M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
PLBC
SCLX
Price
$46.63
$14.53
Analyst Decision
Buy
Hold
Analyst Count
3
1
Target Price
$55.00
N/A
AVG Volume (30 Days)
19.2K
124.5K
Earning Date
01-14-2026
11-14-2025
Dividend Yield
2.56%
N/A
EPS Growth
N/A
N/A
EPS
4.23
N/A
Revenue
$89,868,000.00
$40,360,000.00
Revenue This Year
$21.11
N/A
Revenue Next Year
$16.11
$749.70
P/E Ratio
$11.11
N/A
Revenue Growth
12.51
N/A
52 Week Low
$38.71
$3.60
52 Week High
$49.47
$34.27

Technical Indicators

Market Signals
Indicator
PLBC
SCLX
Relative Strength Index (RSI) 66.27 33.06
Support Level $43.50 $18.34
Resistance Level $47.03 $20.62
Average True Range (ATR) 0.75 1.12
MACD 0.21 -0.51
Stochastic Oscillator 81.24 0.69

Price Performance

Historical Comparison
PLBC
SCLX

About PLBC Plumas Bancorp

Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: